vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $59.3M, roughly 1.4× LIVEPERSON INC). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -77.8%, a 100.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -19.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-12.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -16.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
LivePerson is a global technology company that develops conversational commerce and AI software.
FDMT vs LPSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $59.3M |
| Net Profit | $19.4M | $-46.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | 17.3% | -68.7% |
| Net Margin | 22.8% | -77.8% |
| Revenue YoY | 8508900.0% | -19.0% |
| Net Profit YoY | 139.1% | 58.9% |
| EPS (diluted) | $0.43 | $-9.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $59.3M | ||
| Q3 25 | $90.0K | $60.2M | ||
| Q2 25 | $15.0K | $59.6M | ||
| Q1 25 | $14.0K | $64.7M | ||
| Q4 24 | $1.0K | $73.2M | ||
| Q3 24 | $3.0K | $74.2M | ||
| Q2 24 | $5.0K | $79.9M | ||
| Q1 24 | $28.0K | $85.1M |
| Q4 25 | $19.4M | $-46.1M | ||
| Q3 25 | $-56.9M | $8.7M | ||
| Q2 25 | $-54.7M | $-15.7M | ||
| Q1 25 | $-48.0M | $-14.1M | ||
| Q4 24 | — | $-112.1M | ||
| Q3 24 | $-43.8M | $-28.3M | ||
| Q2 24 | $-35.0M | $41.8M | ||
| Q1 24 | $-32.4M | $-35.6M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 71.4% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.8% | ||
| Q4 24 | — | 77.4% | ||
| Q3 24 | — | 73.1% | ||
| Q2 24 | — | 79.4% | ||
| Q1 24 | — | 71.3% |
| Q4 25 | 17.3% | -68.7% | ||
| Q3 25 | -67983.3% | -24.2% | ||
| Q2 25 | -396373.3% | -10.8% | ||
| Q1 25 | -383007.1% | -26.2% | ||
| Q4 24 | — | -138.0% | ||
| Q3 24 | -1704400.0% | -21.6% | ||
| Q2 24 | -849120.0% | -37.3% | ||
| Q1 24 | -136200.0% | -42.7% |
| Q4 25 | 22.8% | -77.8% | ||
| Q3 25 | -63195.6% | 14.5% | ||
| Q2 25 | -364386.7% | -26.4% | ||
| Q1 25 | -342657.1% | -21.8% | ||
| Q4 24 | — | -153.2% | ||
| Q3 24 | -1461433.3% | -38.1% | ||
| Q2 24 | -699060.0% | 52.3% | ||
| Q1 24 | -115717.9% | -41.8% |
| Q4 25 | $0.43 | $-9.22 | ||
| Q3 25 | $-1.01 | $-2.76 | ||
| Q2 25 | $-0.98 | $-0.17 | ||
| Q1 25 | $-0.86 | $-0.24 | ||
| Q4 24 | — | $-17.23 | ||
| Q3 24 | $-0.79 | $-4.74 | ||
| Q2 24 | $-0.63 | $-0.33 | ||
| Q1 24 | $-0.66 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $95.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $-44.5M |
| Total Assets | $566.7M | $454.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $95.0M | ||
| Q3 25 | $305.1M | $106.7M | ||
| Q2 25 | $293.2M | $162.0M | ||
| Q1 25 | $321.4M | $176.3M | ||
| Q4 24 | $424.9M | $183.2M | ||
| Q3 24 | $501.9M | $142.1M | ||
| Q2 24 | $541.9M | $146.0M | ||
| Q1 24 | $525.9M | $127.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $512.1M |
| Q4 25 | $505.7M | $-44.5M | ||
| Q3 25 | $369.0M | $-22.1M | ||
| Q2 25 | $420.9M | $-82.4M | ||
| Q1 25 | $469.7M | $-74.9M | ||
| Q4 24 | $510.6M | $-67.3M | ||
| Q3 24 | $552.9M | $45.9M | ||
| Q2 24 | $588.3M | $66.6M | ||
| Q1 24 | $600.6M | $19.2M |
| Q4 25 | $566.7M | $454.7M | ||
| Q3 25 | $424.0M | $511.4M | ||
| Q2 25 | $473.6M | $604.2M | ||
| Q1 25 | $515.7M | $596.2M | ||
| Q4 24 | $560.4M | $607.8M | ||
| Q3 24 | $604.0M | $692.0M | ||
| Q2 24 | $620.1M | $703.8M | ||
| Q1 24 | $629.9M | $724.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 26.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $-9.7M |
| Free Cash FlowOCF − Capex | $28.5M | $-12.0M |
| FCF MarginFCF / Revenue | 33.5% | -20.2% |
| Capex IntensityCapex / Revenue | 0.1% | 3.9% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-42.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $-9.7M | ||
| Q3 25 | $-46.5M | $-6.0M | ||
| Q2 25 | $-43.4M | $-11.7M | ||
| Q1 25 | $-47.8M | $-3.1M | ||
| Q4 24 | $-134.6M | $-3.1M | ||
| Q3 24 | $-29.4M | $4.8M | ||
| Q2 24 | $-30.2M | $-17.9M | ||
| Q1 24 | $-29.1M | $1.1M |
| Q4 25 | $28.5M | $-12.0M | ||
| Q3 25 | $-46.6M | $-8.9M | ||
| Q2 25 | $-43.4M | $-14.8M | ||
| Q1 25 | $-48.4M | $-6.9M | ||
| Q4 24 | $-138.4M | $-6.8M | ||
| Q3 24 | $-31.2M | $-230.0K | ||
| Q2 24 | $-30.6M | $-22.9M | ||
| Q1 24 | $-29.8M | $-10.4M |
| Q4 25 | 33.5% | -20.2% | ||
| Q3 25 | -51765.6% | -14.8% | ||
| Q2 25 | -289620.0% | -24.9% | ||
| Q1 25 | -345635.7% | -10.6% | ||
| Q4 24 | -13837100.0% | -9.2% | ||
| Q3 24 | -1038966.7% | -0.3% | ||
| Q2 24 | -611840.0% | -28.7% | ||
| Q1 24 | -106421.4% | -12.2% |
| Q4 25 | 0.1% | 3.9% | ||
| Q3 25 | 101.1% | 4.8% | ||
| Q2 25 | 440.0% | 5.3% | ||
| Q1 25 | 4507.1% | 5.8% | ||
| Q4 24 | 378600.0% | 5.0% | ||
| Q3 24 | 59266.7% | 6.8% | ||
| Q2 24 | 6980.0% | 6.2% | ||
| Q1 24 | 2535.7% | 13.5% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | -0.69× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
